1.Chondrogenic differentiation of mouse bone marrow mesenchymal stem cells induced by cartilage-derived morphogenetic protein-2 in vitro.
Hongtao, TIAN ; Shuhua, YANG ; Liang, XU ; Yukun, ZHANG ; Weihua, XU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2007;27(4):429-32
To study the cartilage differentiation of mouse mesenchymal stem cells (MSCs) induced by cartilage-derived morphogenetic proteins-2 in vitro, the MSCs were isolated from mouse bone marrow and cultured in vitro. The cells in passage 3 were induced into chondrogenic differentiation with different concentrations of recombinant human cartilage-derived morphogenetic proteins-2 (0, 10, 20, 50 and 100 ng/mL). After 14 days of induction, morphology of cells was observed under phase-contrast microscope. Collagen II mRNA and protein were examined with RT-PCR, Western blotting and immunocytochemistry respectively and the sulfate glycosaminoglycan was measured by Alcian blue staining. RT-PCR showed that CDMP-2 could promote expression of collagen II mRNA in an dose-dependant manner, especially at the concentration of 50 ng/mL and 100 ng/mL. Immunocytochemistry and Western blotting revealed a similar change. Alcian blue staining exhibited deposition of typical cartilage extracellular matrix. Our results suggest that mouse bone marrow mesenchymal stem cells can differentiate into chondrogenic phonotype with the induction of CDMP-2 in vitro, which provides a basis for further research on the role of CDMP-2 in chondrogenesis.
Bone Marrow Cells/*cytology
;
Bone Morphogenetic Proteins/*pharmacology
;
Cell Differentiation/*drug effects
;
Cells, Cultured
;
Chondrocytes/*cytology
;
Chondrogenesis/drug effects
;
Chondrogenesis/physiology
;
Mesenchymal Stem Cells/*cytology
;
Recombinant Proteins/pharmacology
2.Mesenchymal stem cells applied in therapy for acute radiation injury.
Ming LI ; Li-Sheng WANG ; Qing-Liang LUO
Journal of Experimental Hematology 2007;15(4):905-908
Mesenchymal stem cells are a kind of non-hematopoietic adult stem cells with selfrenewal and multilineage differentiation potential, which have special biological characteristics, such as secreting hematopoietic growth factors, reconstructing hematopoietic microenvironment, low immunogenicity, and can be transfected and expressed by exogenous gene. This article summarizes the biological characteristics of MSCs and their models of application to acute radiation disease in animals.
Acute Disease
;
Animals
;
Disease Models, Animal
;
Humans
;
Mesenchymal Stem Cell Transplantation
;
Mesenchymal Stromal Cells
;
cytology
;
drug effects
;
physiology
;
Radiation Injuries
;
therapy
3.Differentiation of QY1 bone marrow pluripotential mesenchymal stem cell line cells into cardiomyocytes and vascular endothelial cells in vitro.
Jing YANG ; Qi-Yang XIE ; Hong-Xia XIANG
Journal of Central South University(Medical Sciences) 2007;32(1):93-98
OBJECTIVE:
To explore the differentiation potential of QY1 bone marrow mesenchymal stem cell (MSCs) line cells into cardiacmyocytes and vascular endothelial cells in vitro, to optimize the suitable conditions of MSCs differentiating into cardiomyocytes in vitro, and to examine the potentials of MSCs differentiating into cardiomyogenesis and vasculogenesis.
METHODS:
Specifically committed differentiation inductive medium was employed, including 5-azacytidine for cardiomyogenesis and vascular endothelial growth factor for vasculogenesis in culture respectively in vitro. The differentiated cells were identified by immunohistochemistry and molecular biology.
RESULTS:
MSCs line cells had been cultured in the normal culture medium for 72 hours, then the differentiation inductive medium including 10 micromol/L 5-azacytidine was added into the normal culture dishes for 24 hours only. After that the culture medium was changed back to the normal culture medium. Normal culture medium was changed every 7 days. The second induction was performed after 14 days. The differentiated cells treated with 5-azacytidine could beat spontaneously and formed myotube structures in the optimal induction conditions, and the differentiation rate was (39.47+/-0.56)%. The differentiated cells expressed specific cardiomyocytic proteins identified by the positive immunohistochemistry staining with anti-alpha-sarcomeric antibody and anti-Cx-43 antibody, and also expressed the alpha-myosin heavy chain examined by RT-PCR. The differentiated cells began to appear as the lined up vascular endothelial cells after 48 hour treatment with vascular endothelial growth factor. Some of the differentiated cells connected each other to form vascular endothelial web-like structure after 7 day treatment with vascular endothelial growth factor. On 14 d after treating with vascular endothelial growth factor, the differentiated cells were identified by immunohistochemistry staining. The expressions of both specific surface antibody CD31 and factor VIII for vascular endothelial cells were positive.
CONCLUSION
The cells of QY1 bone marrow mesenchymal stem cell line may differentiate into cardiomyocytes or vascular endothelial cells in vitro under specific condition.
Azacitidine
;
pharmacology
;
Bone Marrow Cells
;
cytology
;
Cell Differentiation
;
drug effects
;
physiology
;
Cell Line
;
Dose-Response Relationship, Drug
;
Endothelial Cells
;
cytology
;
metabolism
;
Factor VIII
;
biosynthesis
;
Humans
;
Immunohistochemistry
;
Mesenchymal Stem Cells
;
cytology
;
Multipotent Stem Cells
;
cytology
;
Myocytes, Cardiac
;
cytology
;
Platelet Endothelial Cell Adhesion Molecule-1
;
biosynthesis
4.Effects of Polycaprolactone-Tricalcium Phosphate, Recombinant Human Bone Morphogenetic Protein-2 and Dog Mesenchymal Stem Cells on Bone Formation: Pilot Study in Dogs.
Sun Jong KIM ; Myung Rae KIM ; Jin Sub OH ; Inho HAN ; Sang Wan SHIN
Yonsei Medical Journal 2009;50(6):825-831
PURPOSE: The aim of this study was to evaluate the survival, proliferation, and bone formation of dog mesenchymal stem cells (dMSCs) in the graft material by using Polycaprolactone-tricalcium phosphate (PCL-TCP), auto-fibrin glue (AFG), recombinant human bone morphogenetic protein-2 (rhBMP-2), and dMSCs after a transplantation to the scapula of adult beagle dogs. MATERIALS AND METHODS: The subjects were two beagle dogs. Total dose of rhBMP-2 on each block was 10 microg with 50 microg/mg concentration. The cortical bone of the scapula of the dog was removed which was the same size of PCL-TCP block (Osteopore International Pte, Singapore; 5.0x5.0x8.0 mm in size), and the following graft material then was fixed with orthodontic mini-implant, Dual-top(R) (Titanium alloy, Jeil Co. Seoul, Korea). Four experimental groups were prepared for this study, Group 1: PCL-TCP + aFG; Group 2: PCL-TCP + aFG + dMSCs; Group 3: PCL-TCP + aFG + dMSCs + rhBMP-2; Group 4: PCL-TCP + aFG + dMSCs + rhBMP-2 + PCL membrane. The survival or proliferation of dMSCs cells was identified with an extracted tissue through a fluorescence microscope, H-E staining and Von-Kossa staining in two weeks and four weeks after the transplantation. RESULTS: The survival and proliferation of dMSCs were identified through a fluorescence microscope from both Group 1 and Group 2 in two weeks and four weeks after the transplantation. Histological observation also found that the injected cells were proliferating well in the G2, G3, and G4 scaffolds. CONCLUSION: This study concluded that bone ingrowth occurred in PCL-TCP scaffold which was transplanted with rhBMP-2, and MSCs did not affect bone growth. More sufficient healing time would be needed to recognize effects of dMSCs on bone formation.
Animals
;
Bone Morphogenetic Proteins/*pharmacology
;
Calcium Phosphates/*pharmacology
;
Cell Proliferation/drug effects
;
Cell Survival/drug effects
;
Cells, Cultured
;
Dogs
;
Fibrin Tissue Adhesive/pharmacology
;
Humans
;
Mesenchymal Stem Cell Transplantation
;
Mesenchymal Stem Cells/*cytology/*drug effects/physiology
;
Microscopy, Fluorescence
;
Osteogenesis/*drug effects
;
Polyesters/*pharmacology
;
Recombinant Proteins/*pharmacology
;
Transforming Growth Factor beta/*pharmacology
5.Chondrogenesis of periodontal ligament stem cells by transforming growth factor-β3 and bone morphogenetic protein-6 in a normal healthy impacted third molar.
Sunyoung CHOI ; Tae-Jun CHO ; Soon-Keun KWON ; Gene LEE ; Jaejin CHO
International Journal of Oral Science 2013;5(1):7-13
The periodontal ligament-derived mesenchymal stem cell is regarded as a source of adult stem cells due to its multipotency. However, the proof of chondrogenic potential of the cells is scarce. Therefore, we investigated the chondrogenic differentiation capacity of periodontal ligament derived mesenchymal stem cells induced by transforming growth factor (TGF)-β3 and bone morphogenetic protein (BMP)-6. After isolation of periodontal ligament stem cells (PDLSCs) from human periodontal ligament, the cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 20% fetal bovine serum (FBS). A mechanical force initiated chondrogenic differentiation of the cells. For chondrogenic differentiation, 10 µg·L⁻¹ TGF-β3 or 100 µg∙L⁻¹ BMP-6 and the combination treating group for synergistic effect of the growth factors. We analyzed the PDLSCs by fluorescence-activated cell sorting and chondrogenesis were evaluated by glycosaminoglycans assay, histology, immunohistochemistry and genetic analysis. PDLSCs showed mesenchymal stem cell properties proved by FACS analysis. Glycosaminoglycans contents were increased 217% by TGF-β3 and 220% by BMP-6. The synergetic effect of TGF-β3 and BMP-6 were shown up to 281% compared to control. The combination treatment increased Sox9, aggrecan and collagen II expression compared with not only controls, but also TGF-β3 or BMP-6 single treatment dramatically. The histological analysis also indicated the chondrogenic differentiation of PDLSCs in our conditions. The results of the present study demonstrate the potential of the dental stem cell as a valuable cell source for chondrogenesis, which may be applicable for regeneration of cartilage and bone fracture in the field of cell therapy.
Adult Stem Cells
;
physiology
;
Aggrecans
;
analysis
;
Bone Morphogenetic Protein 6
;
pharmacology
;
Cell Culture Techniques
;
Cell Differentiation
;
drug effects
;
Cell Separation
;
Chondrogenesis
;
drug effects
;
physiology
;
Collagen Type II
;
analysis
;
Flow Cytometry
;
Glycosaminoglycans
;
analysis
;
Humans
;
Immunohistochemistry
;
Mesenchymal Stromal Cells
;
drug effects
;
physiology
;
Molar, Third
;
cytology
;
Periodontal Ligament
;
cytology
;
drug effects
;
Reverse Transcriptase Polymerase Chain Reaction
;
SOX9 Transcription Factor
;
analysis
;
Stress, Mechanical
;
Tooth, Impacted
;
pathology
;
Transforming Growth Factor beta3
;
pharmacology
6.Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
Jin ZHANG ; Guang-Hui CHEN ; Yong-Wei WANG ; Jing ZHAO ; Hai-Feng DUAN ; Lian-Ming LIAO ; Xiao-Zhong ZHANG ; Yun-Dai CHEN ; Hu CHEN
Chinese Medical Journal 2012;125(19):3472-3478
BACKGROUNDExposure of cells to sublethal concentrations of hydrogen peroxide (H2O2) can alleviate subsequent oxidative stress-induced apoptosis. We assessed the effects of H2O2 preconditioning on the therapeutic potential of human umbilical cord Wharton's Jelly mesenchymal stem cells (WJ-MSCs) in a murine model of myocardial infarction.
METHODSWJ-MSCs were incubated in the media for 2 hours with or without 200 µmol/L H2O2. Mice underwent left anterior descending coronary artery ligation, and received injection of phosphate buffered saline, 1×10(6) WJ-MSCs, or 1×10(6) H2O2 preconditioned WJ-MSCs 3 hours later via tail vein. Echocardiography was performed 0, 7, 14 and 28 days after surgery, and the mice were euthanized on day 28 for histological analysis. In vitro cytokine concentrations in the WJ-MSC cell supernatant were measured by enzyme-linked immunosorbent assay (ELISA). The effect of WJ-MSC cell supernatant on the migration and proliferation of endothelial cells were observed by transwell migration and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazoliumbromide (MTT) assays.
RESULTSEchocardiographic measurements revealed a significant improvement in the left ventricular contractility of the WJ-MSCs-H2O2 group compared to the WJ-MSCs group. Histological analysis revealed increased neovascularization and reduced myocardial fibrosis in the WJ-MSCs-H2O2 group compared to the WJ-MSCs group. Pretreatment of WJ-MSCs with H2O2 increased the secretion of interleukin-6 (IL-6) into the cell culture supernatant by approximately 25-fold. The culture supernatant from WJ-MSCs-H2O2 significantly increased the migration and proliferation of endothelial cells; these effects could be blocked using an anti-IL-6 antibody.
CONCLUSIONSThis study demonstrates that H2O2 preconditioning significantly enhanced the therapeutic potential of WJ-MSCs, possibly by stimulating the production of IL-6 by WJ-MSCs, which may cause migration and proliferation of endothelial cells and increase neovascularization.
Animals ; Cell Movement ; physiology ; Echocardiography ; Enzyme-Linked Immunosorbent Assay ; Humans ; Hydrogen Peroxide ; pharmacology ; Immunohistochemistry ; Interleukin-6 ; metabolism ; Male ; Mesenchymal Stem Cell Transplantation ; Mesenchymal Stromal Cells ; drug effects ; metabolism ; Mice ; Mice, Inbred C57BL ; Myocardial Infarction ; pathology ; therapy ; Reactive Oxygen Species ; metabolism ; Wharton Jelly ; cytology